Reference Values for Videofluoroscopic Measures of Swallowing
NCT ID: NCT05497219
Last Updated: 2025-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
580 participants
INTERVENTIONAL
2022-11-15
2027-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Diagnostic Standards in Dysphagia
NCT04773184
Mechanisms Preventing Pharyngeal Reflux
NCT05696184
Interpretation of Transnasal Esophagoscopy Findings
NCT00372918
Esophageal Impedance and Manometry Measurements and Dysphagia Symptom Scoring
NCT04503785
Bedside Screening Method for Patients With Potential Swallowing Impairment
NCT01158313
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In a previous study, the investigators developed a rigorous method for measuring swallowing physiology from VF: the Analysis of Swallowing Physiology: Events, Kinematics and Timing (ASPEKT Method). That study led to publication of initial ASPEKT reference values from 40 young healthy adults (\<60 years) and preliminary analyses comparing data from healthy older adults and small cohorts of adults with dysphagia to these reference data.
In this project, the investigtors will:
* validate the ASPEKT Method healthy reference values for swallowing across the adult life span; and
* profile swallowing patho-physiology in clinical groups where dysphagia is a cause of morbidity to identify clinical decision points that can be used for diagnosis and outcome measurement.
This study will explore the following research questions:
Research Question 1: Will \> 5% of healthy adult participants in a new sample show ASPEKT values outside the common reference interval calculated in a prior sample? • VF measures will be collected in a prospective sample of 280 healthy adults, controlling for sex, age, and bolus consistency. Updated reference interval boundaries for healthy swallowing will be calculated.
Research Question 2: Do specific clinical conditions present with specific patterns of swallowing pathophysiology?
• VF measures will be prospectively collected in 3 high-risk dysphagia cohorts: adults with Parkinson Disease, Chronic Obstructive Pulmonary Disease, adults in the acute stage post-stroke. Values for these clinical cohorts will be compared to age- and sex-matched reference values from healthy participants. This will delineate swallowing impairment profiles to inform clinical decision points for diagnosis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy adults
Adults aged 18 or older with no history of swallowing impairment
Videofluoroscopic Swallowing Study (VF)
A videofluoroscopy (VF) is a dynamic radiological evaluation of swallowing in which the participant swallows liquid or food boluses of different consistencies prepared with barium contrast. The x-rays are recorded at 30 frames per second.
Parkinson Disease
Adults with a neurologist-confirmed diagnosis of Parkinson Disease who also report symptoms of swallowing impairment, defined as a score \>/= 200 on the Sydney Swallow Questionnaire.
Videofluoroscopic Swallowing Study (VF)
A videofluoroscopy (VF) is a dynamic radiological evaluation of swallowing in which the participant swallows liquid or food boluses of different consistencies prepared with barium contrast. The x-rays are recorded at 30 frames per second.
Chronic Obstructive Pulmonary Disease
Adults with a respirologist-confirmed diagnosis of Chronic Obstructive Pulmonary Disease who also report symptoms of swallowing impairment, defined as a score \>/= 200 on the Sydney Swallow Questionnaire.
Videofluoroscopic Swallowing Study (VF)
A videofluoroscopy (VF) is a dynamic radiological evaluation of swallowing in which the participant swallows liquid or food boluses of different consistencies prepared with barium contrast. The x-rays are recorded at 30 frames per second.
Acute Stroke
Adult inpatients in the acute stage post stroke who are referred for swallowing assessment.
Videofluoroscopic Swallowing Study (VF)
A videofluoroscopy (VF) is a dynamic radiological evaluation of swallowing in which the participant swallows liquid or food boluses of different consistencies prepared with barium contrast. The x-rays are recorded at 30 frames per second.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Videofluoroscopic Swallowing Study (VF)
A videofluoroscopy (VF) is a dynamic radiological evaluation of swallowing in which the participant swallows liquid or food boluses of different consistencies prepared with barium contrast. The x-rays are recorded at 30 frames per second.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Clinical cohorts: physician confirmed diagnosis of the condition of interest plus symptoms of swallowing difficult, defined as a score \>/=200 on the Sydney Swallow Questionnaire.
Exclusion Criteria
* known allergies to latex, due to the possibility that these items will come into contact with the oral mucosa during data collection
* current pregnancy
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Florida
OTHER
McMaster University
OTHER
National Institute on Aging (NIA)
NIH
Ohio State University
OTHER
University of Cincinnati
OTHER
University Health Network, Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Catriona M Steele, PhD
Role: PRINCIPAL_INVESTIGATOR
University Health Network, Toronto
Emily K Plowman, PhD
Role: PRINCIPAL_INVESTIGATOR
Ohio State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Florida
Gainesville, Florida, United States
University of Cincinnati Medical Center
Cincinnati, Ohio, United States
The Ohio State University
Columbus, Ohio, United States
McMaster University
Hamilton, Ontario, Canada
University Health Network
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-6019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.